Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100042946Phase 4Recruiting
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: Basic vital signs at each observation time point, Operation time, recovery time, VAS pain score, satisfaction, and other recovery-related indicators and 1 more. Started Feb 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100042946.